Your browser doesn't support javascript.
loading
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.
Kongkiatkamon, Sunisa; Terkawi, Laila; Guan, Yihong; Adema, Vera; Hasipek, Metis; Dombrovski, Tatiana; Co, Milo; Walter, Wencke; Awada, Hassan; Parker, Yvonne; Hutter, Stephan; Pagliuca, Simona; Gurnari, Carmelo; Rogers, Heesun J; Meggendorfer, Manja; Lindner, Daniel J; Haferlach, Torsten; Visconte, Valeria; LaFramboise, Thomas; Jha, Babal K; Maciejewski, Jaroslaw P.
Afiliação
  • Kongkiatkamon S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Terkawi L; Research Unit in Translational Hematology, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Guan Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Adema V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hasipek M; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Dombrovski T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Co M; Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Walter W; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Awada H; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Parker Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hutter S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Pagliuca S; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Rogers HJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Meggendorfer M; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Lindner DJ; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Haferlach T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Visconte V; MLL Munich Leukemia Laboratory, Munich, Germany.
  • LaFramboise T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Jha BK; Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Leukemia ; 36(8): 2086-2096, 2022 08.
Article em En | MEDLINE | ID: mdl-35761024
ABSTRACT
Myeloperoxidase (MPO) gene alterations with variable clinical penetrance have been found in hereditary MPO deficiency, but their leukemia association in patients and carriers has not been established. Germline MPO alterations were found to be significantly enriched in myeloid neoplasms 28 pathogenic/likely pathogenic variants were identified in 100 patients. The most common alterations were c.2031-2 A > C, R569W, M519fs* and Y173C accounting for about half of the cases. While functional experiments showed that the marrow stem cell pool of Mpo-/- mice was not increased, using competitive repopulation demonstrated that Mpo-/- grafts gained growth advantage over MPO wild type cells. This finding also correlated with increased clonogenic potential after serial replating in the setting of H2O2-induced oxidative stress. Furthermore, we demonstrated that H2O2-induced DNA damage and activation of error-prone DNA repair may result in secondary genetic damage potentially predisposing to leukemia leukemic evolution. In conclusion, our study for the first time demonstrates that germline MPO variants may constitute risk alleles for MN evolution.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Transtornos Mieloproliferativos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Transtornos Mieloproliferativos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos